The U.S. Food and Drug Administration has approved clearance for a new acne treatment that selectively targets sebaceous glands, according to a news release.
Acne Treatment and Compliance Resource Center
The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.
Facial care advice for patients with acne
While both benzoyl peroxide acne preparations and vitamin C products carry benefits in acne treatment, it’s wise to recall the characteristics of each element in advising patients on caring for their skin. Vitamin C is rapidly oxidized with exposure to air. Benzoyl peroxide is an oxidant. This is how Dr. Draelos suggests these products be used.
Data suggest photodynamic therapy with the investigational topical methyl aminolevulinate may be an effective treatment for patients with severe facial acne.
Results from three phase 3 trials, suggest ixekizumab (Talz, Eli Lilly & Company) is effective through 60 weeks of treatment among patients with moderate-to-severe plaque psoriasis.
The acne app offers a free and immediate analysis of acne type and severity; develops an individualized acne control plan; and monitors users’ progress. It aims to help consumers diagnose, treat, manage and prevent acne.
Researchers reveal that patients may have concerns with acne consultations. The authors offer tips to improve acne consults.
Acne presents with certain nuances in darker skin patients. Exacerbating factors, treatment approaches and desired treatment outcomes may differ from lighter skin patients.
Researchers report on survey findings that shed light on why patients find acne consultations ineffective.
The investigational sebum-inhibiting topical DRM01 had positive results in a phase 2b study, which paves the way for phase 3 trials planned for 2017.